MyMedR

Displaying publications 21 - 40 of 240 in total

Abstract:

Sort:

Fulltext A transition from the BPharm to the PharmD degree in five selected countries

Supapaan T, Low BY, Wongpoowarak P, Moolasarn S, Anderson C

Pharm Pract (Granada), 2019 08 21;17(3):1611.
PMID: 31592299 DOI: 10.18549/PharmPract.2019.3.1611

This review focuses on the studies and opinions around issues of transition from the BPharm to the PharmD degree in the U.S., Japan, South Korea, Pakistan and Thailand. The transition to the clinically orientated PharmD degree in many countries was seen to be a means of developing the profession. However, some countries have both clinically-oriented and pharmaceutical sciences-oriented PharmD programme that are designed to meet the needs of their countries. Each country created a different process to handle the transition to an all-PharmD programme, but mostly had the process of school accreditation mandated by the regulatory bodies. The main barrier to the transition in most of the countries was the issue of educational quality. A set of indicators is needed to measure and monitor the impact/outcome of the PharmD degree. Each country has different needs due to the different contexts of health care systems and the scope of pharmacy practice. In order to increase their chances of benefiting from the new programme, academic leaders should critically assess their countries' needs before deciding to adopt a PharmD programme.

Matched MeSH terms: Republic of Korea
Author's reply to editorial comment to sex among Asian men and women: The global better sex survey in Asia

Tan HM

International Journal of Urology, 2009;16:515.
DOI: 10.1111/j.1442-2042.2009.02295.x
Matched MeSH terms: Korea
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with early breast cancer: a KSMO-ESMO initiative endorsed by CSCO, ISMPO, JSMO, MOS, SSO and TOS

Park YH, Senkus-Konefka E, Im SA, Pentheroudakis G, Saji S, Gupta S, et al.

Ann Oncol, 2020 04;31(4):451-469.
PMID: 32081575 DOI: 10.1016/j.annonc.2020.01.008

In view of the planned new edition of the most recent version of the European Society for Medical Oncology (ESMO) Clinical Practice Guidelines for the diagnosis, treatment and follow-up of primary breast cancer published in 2015, it was decided at the ESMO Asia Meeting in November 2018, by both the ESMO and the Korean Society of Medical Oncology (KSMO), to convene a special face-to-face guidelines meeting in 2019 in Seoul. The aim was to adapt the latest ESMO 2019 guidelines to take into account the ethnic and geographical differences associated with the treatment of early breast cancer in Asian patients. These guidelines represent the consensus opinions reached by experts in the treatment of patients with early breast cancer representing the oncology societies of Korea (KSMO), China (CSCO), India (ISMPO) Japan (JSMO), Malaysia (MOS), Singapore (SSO) and Taiwan (TOS). The voting was based on scientific evidence, and was independent of both the current treatment practices, and the drug availability and reimbursement situations, in the individual participating Asian countries.

Matched MeSH terms: Republic of Korea
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with intermediate and advanced/relapsed hepatocellular carcinoma: a TOS-ESMO initiative endorsed by CSCO, ISMPO, JSMO, KSMO, MOS and SSO

Chen LT, Martinelli E, Cheng AL, Pentheroudakis G, Qin S, Bhattacharyya GS, et al.

Ann Oncol, 2020 03;31(3):334-351.
PMID: 32067677 DOI: 10.1016/j.annonc.2019.12.001

The most recent version of the European Society for Medical Oncology (ESMO) Clinical Practice Guidelines for the diagnosis, treatment and follow-up of hepatocellular carcinoma (HCC) was published in 2018, and covered the diagnosis, management, treatment and follow-up of early, intermediate and advanced disease. At the ESMO Asia Meeting in November 2018 it was decided by both the ESMO and the Taiwan Oncology Society (TOS) to convene a special guidelines meeting immediately after the Taiwan Joint Cancer Conference (TJCC) in May 2019 in Taipei. The aim was to adapt the ESMO 2018 guidelines to take into account both the ethnic and the geographic differences in practice associated with the treatment of HCC in Asian patients. These guidelines represent the consensus opinions reached by experts in the treatment of patients with intermediate and advanced/relapsed HCC representing the oncology societies of Taiwan (TOS), China (CSCO), India (ISMPO) Japan (JSMO), Korea (KSMO), Malaysia (MOS) and Singapore (SSO). The voting was based on scientific evidence, and was independent of the current treatment practices, the drug availability and reimbursement situations in the individual participating Asian countries.

Matched MeSH terms: Republic of Korea
Fulltext Grey System Theory in the Study of Medical Tourism Industry and Its Economic Impact

Dang HS, Nguyen TM, Wang CN, Day JD, Dang TMH

Int J Environ Res Public Health, 2020 02 04;17(3).
PMID: 32033177 DOI: 10.3390/ijerph17030961

The Asia-Pacific region is known as a favorite destination for global medical travelers due to its medical expertise, innovative technology, safety, attractive tourism destination and cost advantage in the recent decade. This study contributes to propose an approach which effectively assesses performance of medical tourism industry based on considering the economic impact factors as well as provides a conceptual framework for the industry analysis. Grey system theory is utilized as a major analyzing approach. According to that, factors impact on the sustainable development of medical tourism in Asia-Pacific region could be identified. The performance of each destination in this region was simultaneously revealed. The results presented an overall perspective of the medical tourism industry in the scope of the Asia-Pacific region, and in Taiwan particularly. Data was collected on six major destinations including Singapore, Thailand, India, South Korea, Malaysia and Taiwan. The results proved that tourism sources and healthcare medical infrastructures play a crucial role in promoting the healthcare travel industry, while cost advantage and marketing effectiveness were less considered. In addition, performance analyse indicated that Thailand has a good performance and stands in the top ranking, followed by Malaysia, India, Singapore, South Korea and Taiwan, respectively. The revenue of Taiwan has increased slowly in the last six years, with a market worth approximately NT$20.5 billion, and the number of medical travelers is expected to increase to 777,523 by 2025. The findings of this study are expected to provide useful information for the medical tourism industry and related key players in strategic planning.

Matched MeSH terms: Republic of Korea
Changing trends in viral hepatitis mortality in East and Southeast Asia between 1987 and 2015 and its prediction until 2030

Wu J, Wang HL, Liu X, Ding C, Zhou Y, Fu X, et al.

Liver Int, 2020 02;40(2):298-307.
PMID: 31674705 DOI: 10.1111/liv.14289

BACKGROUND & AIMS: Trends in long-term mortality rates for viral hepatitis in East and Southeast Asia have been rarely reported. The aim of our study was to explore the long-term trends in viral hepatitis mortality rates in East and Southeast Asian countries between 1987 and 2015 and provide predictions of mortality to 2030.
METHODS: We obtained viral hepatitis mortality data from the WHO Mortality Database for six East and Southeast Asian countries between 1987 and 2015. We produced choropleth maps of viral hepatitis mortality rates in 1987 and 2015 in East and Southeast Asia to illustrate geographic variations. We made predictions of mortality rates for each included country until the year 2030 using a series of joinpoint models.
RESULTS: Viral hepatitis mortality rates declined in China (the average annual percent change (AAPC) = -5.1%, 95% CI: -7.5, -2.6), Singapore (AAPC = -5.4%, 95% CI: -7.5, -3.2), and the Philippines (AAPC = -3.4%, 95% CI: -4.9, -1.8). In contrast, Japan, the Republic of Korea, and Malaysia have experienced increasing trends in mortality rates, followed by decreasing trends. Our predictions indicate that all countries will experience slight to moderate downward trends until 2030.
CONCLUSION: Favourable decreasing trends have been noted in East and Southeast Asian countries, which may not only inform the control and management of viral hepatitis in this region but also guide the prevention of viral hepatitis deaths in another region with a similar viral hepatitis epidemic.

Matched MeSH terms: Republic of Korea
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with locally-advanced unresectable non-small-cell lung cancer: a KSMO-ESMO initiative endorsed by CSCO, ISMPO, JSMO, MOS, SSO and TOS

Park K, Vansteenkiste J, Lee KH, Pentheroudakis G, Zhou C, Prabhash K, et al.

Ann Oncol, 2020 02;31(2):191-201.
PMID: 31959336 DOI: 10.1016/j.annonc.2019.10.026

The most recent version of the European Society for Medical Oncology (ESMO) Clinical Practice Guidelines for the diagnosis, treatment and follow-up of early and locally-advanced non-small-cell lung cancer (NSCLC) was published in 2017, and covered the diagnosis, staging, management and treatment of both early stage I and II disease and locally-advanced stage III disease. At the ESMO Asia Meeting in November 2018, it was decided by both the ESMO and the Korean Society of Medical Oncology (KSMO) to convene a special face-to-face guidelines meeting in 2019 in Seoul. The aim was to adapt the ESMO 2017 guidelines to take into account potential differences related to ethnicity, cancer biology and standard practices associated with the treatment of locally-advanced, unresectable NSCLC in Asian patients. These guidelines represent the consensus opinions reached by those experts in the treatment of patients with lung cancer who represented the oncology societies of Korea (KSMO), China (CSCO), India (ISMPO), Japan (JSMO), Malaysia (MOS), Singapore (SSO) and Taiwan (TOS). The voting was based on scientific evidence, and it was independent of both local current treatment practices and the treatment availability and reimbursement situations in the individual participating Asian countries.

Matched MeSH terms: Republic of Korea
First predatory journals, now conferences: The need to establish lists of fake conferences

Sonne C, Ok YS, Lam SS, Rinklebe J, Alstrup AKO, Kim KH

Sci Total Environ, 2020 May 01;715:136990.
PMID: 32014787 DOI: 10.1016/j.scitotenv.2020.136990

Science of the Total Environment recently discussed how open access and predatory journals affect the flow of scientific knowledge in an unfortunate way. Now, South Korea's Ministry of Education is intervening to establish a system that will help its researchers avoid the growing global number of fake conferences of low academic and scientific merit. Here, we discuss solutions to this problem with respect to what is needed. Particularly, a list similar to that of Beall's for predatory conferences, without restricting researchers' academic freedom.

Matched MeSH terms: Republic of Korea
Fulltext Functionalized KIT-6/Polysulfone Mixed Matrix Membranes for Enhanced CO2/CH4 Gas Separation

Chew TL, Ding SH, Oh PC, Ahmad AL, Ho CD

Polymers (Basel), 2020 Oct 09;12(10).
PMID: 33050226 DOI: 10.3390/polym12102312

The development of mixed matrix membranes (MMMs) for effective gas separation has been gaining popularity in recent years. The current study aimed at the fabrication of MMMs incorporated with various loadings (0-4 wt%) of functionalized KIT-6 (NH2KIT-6) [KIT: Korea Advanced Institute of Science and Technology] for enhanced gas permeation and separation performance. NH2KIT-6 was characterized by field emission scanning electron microscope (FESEM), X-ray diffraction (XRD), Fourier transform infrared (FTIR), and N2 adsorption-desorption analysis. The fabricated membranes were subjected to FESEM and FTIR analyses. The effect of NH2KIT-6 loading on the CO2 permeability and ideal CO2/CH4 selectivity of the fabricated membranes were investigated in gas permeation and separation studies. The successfulness of (3-Aminopropyl) triethoxysilane (APTES) functionalization on KIT-6 was confirmed by FTIR analysis. As observed from FESEM images, MMMs with no voids in the matrix were successfully fabricated at a low NH2KIT-6 loading of 0 to 2 wt%. The CO2 permeability and ideal CO2/CH4 selectivity increased when NH2KIT-6 loading was increased from 0 to 2 wt%. However, a further increase in NH2KIT-6 loading beyond 2 wt% led to a drop in ideal CO2/CH4 selectivity. In the current study, a significant increase of about 47% in ideal CO2/CH4 selectivity was achieved by incorporating optimum 2 wt% NH2KIT-6 into the MMMs.

Matched MeSH terms: Republic of Korea
[Discrimination of geographic strains of periodic Brugia malayi by the cuticular ornamentation of the male]

Bain O, Chandrasekharan SA, Partono F, Mak JW, Zheng HJ, Seo BS, et al.

Ann Parasitol Hum Comp, 1988;63(3):209-23.
PMID: 3190122

A comparative study of five periodic human strains of Brugia malayi, originating from India, China, Korea, Malaysia and Indonesia, is given. This morphological analysis is based on males; the "standard" characters (oesophagus, papillae, spicules...) appear identical. On the contrary, the cuticular ornamentation of the posterior region--which is composed of the area rugosa and of a system of bosses and constitutes a secondary non-skid copulatory apparatus--differs following the geographical origin of the strain. A key is given, based on this character. 1(2) At 800-1,200 micron from the tip of tail, numerous cuticular bosses present on the right side of the body (fig. 2 and 8 B). 2(1) At 800-1,200 micron from the tip of tail, cuticular bosses absent or scarce on the right side of the body (fig. 8 D). 3(4) At 1,800-1,200 micron from the tip of tail (fig. 4), scarce and slightly projecting cuticular bosses on the dorsal side of the body contrasting with well projecting lateral cuticular bosses (fig. 9 E and F). Anterior extremity of the area rugosa made by a few stripes of tiny bosses linked transversally (fig. 9 A). 4(3) At 1,800-2,200 micron, numerous cuticular bosses on the dorsal side of the body (figs. 5, 6 and 7). Anterior extremity of the area rugosa made by the stripes of longitudinal rods (fig. 9C). 5(6) Oblong transversally stretched cuticular bosses on the dorsal and left sides of the body, anteriorly to the area rugosa (fig. 5); big oblong bosses on the left side (fig. 9 B). Transversal wrinkles and stripes of rods absent on the dorsal side of the body. 6(5) Round cuticular bosses on the dorsal and left sides of the body anteriorly to the area rugosa (figs. 6 and 7): no big oblong bosses on the left side. Transversal wrinkles or stripes of rods present on the dorsal side of the body (fig. 9 D). Nomenclaturally, such differences could be used in defining different taxa, but it could be useful to perform "blind determination" (material without labelling), to study conveniently the morphology of microfilariae (often an excellent indication for speciation in that group of Nematodes) and, evenly, to proceed to parallel studies on isoenzymes. However, whatever could be the taxonomical conclusion, the differences observed in Brugia malayi originating from different regions appear to the sufficient to consider the existence of four distinct diseases.

Matched MeSH terms: Korea
The human environment in Korea

Park K

Med J Malaysia, 1974 Dec;29(2):111-4.
PMID: 4282395
Matched MeSH terms: Korea
Fifth meeting of the Eastern Regional Committee of the International Union against Tuberculosis

Harvey C

Med J Aust, 1967 Feb 11;1(6):302-4.
PMID: 4381144
Matched MeSH terms: Korea
The periodicity of the microfilariae of Brugia malayi in Cheju Island, Korea

Seo BS

Kisaengchunghak Chapchi, 1974 Dec;12(2):95-100.
PMID: 12913470

The periodicity of the microfilariae of Brugia malayi was studied in 9 human carriers from Shin-san Ri, Seong-san Myon, Cheju Island. The periodicity pattern was markedly nocturnal and the peaks were observed between 21:30 p.m. and 5:30 a.m. The average peak count was 1:30 a.m. and the percentage of peak count at this time was 95.3. The ratio of minimum of the average peak count percentage to the maximum was 8.3. The periodicity pattern of B.malayi in Cheju Island was compared with that in Inland and no differences were found between two forms. From the above observations, it was concluded that the periodicity of B. malayi in Korea is markedly nocturnal and closely resembles that in the strain of Penang, Malaya.

Matched MeSH terms: Republic of Korea
Fulltext The Current Situation Regarding Long-Acting Insulin Analogues Including Biosimilars Among African, Asian, European, and South American Countries; Findings and Implications for the Future

Godman B, Haque M, Leong T, Allocati E, Kumar S, Islam S, et al.

Front Public Health, 2021;9:671961.
PMID: 34249838 DOI: 10.3389/fpubh.2021.671961

Background: Diabetes mellitus rates continue to rise, which coupled with increasing costs of associated complications has appreciably increased global expenditure in recent years. The risk of complications are enhanced by poor glycaemic control including hypoglycaemia. Long-acting insulin analogues were developed to reduce hypoglycaemia and improve adherence. Their considerably higher costs though have impacted their funding and use. Biosimilars can help reduce medicine costs. However, their introduction has been affected by a number of factors. These include the originator company dropping its price as well as promoting patented higher strength 300 IU/ml insulin glargine. There can also be concerns with different devices between the manufacturers. Objective: To assess current utilisation rates for insulins, especially long-acting insulin analogues, and the rationale for patterns seen, across multiple countries to inform strategies to enhance future utilisation of long-acting insulin analogue biosimilars to benefit all key stakeholders. Our approach: Multiple approaches including assessing the utilisation, expenditure and prices of insulins, including biosimilar insulin glargine, across multiple continents and countries. Results: There was considerable variation in the use of long-acting insulin analogues as a percentage of all insulins prescribed and dispensed across countries and continents. This ranged from limited use of long-acting insulin analogues among African countries compared to routine funding and use across Europe in view of their perceived benefits. Increasing use was also seen among Asian countries including Bangladesh and India for similar reasons. However, concerns with costs and value limited their use across Africa, Brazil and Pakistan. There was though limited use of biosimilar insulin glargine 100 IU/ml compared with other recent biosimilars especially among European countries and Korea. This was principally driven by small price differences in reality between the originator and biosimilars coupled with increasing use of the patented 300 IU/ml formulation. A number of activities were identified to enhance future biosimilar use. These included only reimbursing biosimilar long-acting insulin analogues, introducing prescribing targets and increasing competition among manufacturers including stimulating local production. Conclusions: There are concerns with the availability and use of insulin glargine biosimilars despite lower costs. This can be addressed by multiple activities.

Matched MeSH terms: Republic of Korea
Fulltext Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis treatment and follow-up of patients with localised colon cancer

Yoshino T, Argilés G, Oki E, Martinelli E, Taniguchi H, Arnold D, et al.

Ann Oncol, 2021 12;32(12):1496-1510.
PMID: 34411693 DOI: 10.1016/j.annonc.2021.08.1752

The most recent version of the European Society for Medical Oncology (ESMO) Clinical Practice Guidelines for the diagnosis, treatment and follow-up of localised colon cancer was published in 2020. It was decided by both the ESMO and the Japanese Society of Medical Oncology (JSMO) to convene a special virtual guidelines meeting in March 2021 to adapt the ESMO 2020 guidelines to take into account the ethnic differences associated with the treatment of localised colon cancer in Asian patients. These guidelines represent the consensus opinions reached by experts in the treatment of patients with localised colon cancer representing the oncological societies of Japan (JSMO), China (CSCO), India (ISMPO), Korea (KSMO), Malaysia (MOS), Singapore (SSO) and Taiwan (TOS). The voting was based on scientific evidence and was independent of the current treatment practices and drug availability and reimbursement situations in the different Asian countries.

Matched MeSH terms: Republic of Korea
Fulltext Logic mining in league of legends

Liew, Ching Kho, Mohd Shareduwan Mohd Kasihmuddin, Mohd. Asyraf Mansor, Sathasivam, Saratha

Pertanika Journal of Science & Technology, 2020;28(1):211-225.
MyJurnal

Since its debut in 2009, League of Legends (LoL) has been on a rise in becoming an extremely favoured multiplayer online battle arena (MOBA) game. This paper presented a logic mining technique to model the results (Win / Lose) of the LoL games played in 3 regions, namely South Korea, North America and Europe. In this research, a method named k satisfiability based reverse analysis method (kSATRA) was brought forward to obtain the logical relationship among the gameplays and objectives in the game. The logical rule obtained from the LoL games was used to categorize the results of future games. kSATRA made use of the advantages of Hopfield Neural Network and k Satisfiability representation. The data set used in this study included the data of all 10 teams from each region, which composed of all games from Spring Season 2018. The effectiveness of kSATRA in obtaining logical rule in LoL games was tested based on root mean square error (RMSE), mean absolute error (MAE), mean absolute percentage error (MAPE) and CPU time. Results acquired from the computer simulation showed the robustness of kSATRA in exhibiting the performance of the LoL teams.

Matched MeSH terms: Republic of Korea
Metabolic events associated with the use of antipsychotics in children, adolescents and young adults: a multinational sequence symmetry study

Man KKC, Shao SC, Chaiyakunapruk N, Dilokthornsakul P, Kubota K, Li J, et al.

Eur Child Adolesc Psychiatry, 2022 Jan;31(1):99-120.
PMID: 33185773 DOI: 10.1007/s00787-020-01674-6

It is known that younger patients treated with antipsychotics are at increased risk of metabolic events; however, it is unknown how this risk varies according to ethnicity, the class of antipsychotic and the specific product used, and by age group. We conducted a multinational sequence symmetry study in Asian populations (Hong Kong, Japan, Korea, Taiwan and Thailand) and non-Asian populations (Australia and Denmark) to evaluate the metabolic events associated with antipsychotics in both Asian and non-Asian populations, for typical and atypical antipsychotics, and by the subgroups of children and adolescents, and young adults. Patients aged 6-30 years newly initiating oral antipsychotic drugs were included. We defined a composite outcome for metabolic events which included dyslipidemia, hypertension and hyperglycemia. We calculated the sequence ratio (SR) by dividing the number of people for whom a medicine for one of the outcome events was initiated within a 12-month period after antipsychotic initiation by the number before antipsychotic initiation. This study included 346,904 antipsychotic initiators across seven countries. Antipsychotic use was associated with an increased risk of composite metabolic events with a pooled adjusted SR (ASR) of 1.22 (95% CI 1.00-1.50). Pooled ASRs were similar between Asian (ASR, 1.22; 95% CI 0.88-1.70) and non-Asian populations (ASR, 1.22; 95% CI 1.04-1.43). The pooled ASR for typical and atypical antipsychotics was 0.98 (95% CI 0.85-1.12) and 1.24 (95% CI 0.97-1.59), respectively. No difference was observed in the relative effect in children and adolescents compared to young adults. The risk of metabolic events associated with antipsychotics use was similar in magnitude in Asian and non-Asian populations despite the marked difference in drug utilization patterns.

Matched MeSH terms: Republic of Korea
Fulltext Delay in Vaccine Access in ASEAN Countries

Subsittipong N, Choi J, Kim TH, Han E

Int J Environ Res Public Health, 2022 Mar 22;19(7).
PMID: 35409470 DOI: 10.3390/ijerph19073786

Background: The introduction of new vaccines has been delayed in some countries in the Asia-Pacific region, which has led to delays in accessing vaccines for target patients. However, the approval lag of vaccines in the Asia-Pacific region has not been assessed. The objective of this study is to assess the availability and approval lag of vaccines in Asia-Pacific countries and compare them among Asia-Pacific countries, the United States (US), and Europe (EU). Methods: The information on vaccines prequalified by the World Health Organization (WHO) between 2010 and 2019 was obtained primarily from the WHO website. The date of approval of the WHO prequalified vaccine in Australia, India, South Korea, Thailand, Singapore, Malaysia, the US, and EU was retrieved from the official website of national regulatory agencies. The vaccines were divided into two groups based on their first approval pathway, that is, vaccines that were first approved by SRA (Stringent Regulatory Authority including the US, EU, and WHO) and those that were first approved by non-SRA. The absolute approval lag represented the availability of the vaccine. Relative approval lag represented the lag time between the approval date of the country of interest and the first global approval date and was measured as the median approval lag. A Mann−Whitney U test was used to examine statistical differences between relative approval lag between the SRA first and the non-SRA first groups. Results: A total of 92 vaccines were prequalified by the WHO between 2010 and 2019, but only 61 vaccines were included in the analysis. Over 50% of vaccines were first licensed by non-SRAs. Of all the WHO-prequalified vaccines, the median approval lag in the ASEAN countries in this study was longer than those in the US and EU, with a median of 30 months in Australia, 15 months in South Korea, 52 months in Thailand, and 23 months in Singapore, compared to 0 months in the US and EU. The differences in approval lags between SRA first vaccines and non-SRA first vaccines were statistically significant in South Korea and Thailand (p < 0.05). Conclusions: The approval lag of vaccines was observed in the Asia-Pacific region, indicating a gap between the Asia-pacific region and the US and EU in regard to access to new vaccines. Future studies need to analyze the background factors related to the gap in availability and vaccine approval lag in the Asia-Pacific region and assess the impact of vaccine approval lag in the region.

Matched MeSH terms: Republic of Korea
Real-world insights of patient voices with age-related macular degeneration in the Republic of Korea and Taiwan: an AI-based Digital Listening study by Semantic-Natural Language Processing

Jeon H, Yu SY, Chertkova O, Yun H, Ng YL, Lim YY, et al.

BMC Med Inform Decis Mak, 2025 Mar 18;25(1):137.
PMID: 40102785 DOI: 10.1186/s12911-025-02929-5

BACKGROUND: In this era of active online communication, patients increasingly share their healthcare experiences, concerns, and needs across digital platforms. Leveraging these vast repositories of real-world information, Digital Listening enables the systematic collection and analysis of patient voices through advanced technologies. Semantic-NLP artificial intelligence, with its ability to process and extract meaningful insights from large volumes of unstructured online data, represents a novel approach for understanding patient perspectives. This study aimed to demonstrate the utility of Semantic-NLP technology in presenting the needs and concerns of patients with age-related macular degeneration (AMD) in Korea and Taiwan.
METHODS: Data were collected and analysed over three months from January 2023 using an ontology-based information extraction system (Semantic Hub). The system identified patient "stories" and extracted themes from online posts from January 2013 to March 2023, focusing on Korea and Taiwan by filtering the geographic location of users, the language used, and the local online platforms. Extracted texts were structured into knowledge graphs and analysed descriptively.
RESULTS: The patient voice was identified in 133,857 messages (9,620 patients) from the Naver online platform in Korea and included internet chat forums focused on macular degeneration. The most important factors for AMD treatments were effectiveness (1,632/3,401 mentions; 48%), price and access to insurance (33%), tolerability (10%) and doctor and clinic recommendations (9%). Treatment burden associated with intravitreal injection of vascular endothelial growth factor inhibitors related to tolerability (254/942 mentions; 27%), financial burden (20%), hospital selection (18%) and emotional burden (14%). In Taiwan, 444 messages were identified from Facebook, YouTube and Instagram. The success of treatment was judged by improvements in visual acuity (20/121 mentions; 16.5%), effect on oedema (10.7%), less distortion (9.1%) and inhibition of angiogenesis (5.8%). Tolerability concerns were rarely mentioned (26/440 mentions; 5.9%).
CONCLUSIONS: Digital Listening using Semantic-NLP can provide real-world insights from large amounts of internet data quickly and with low human labour cost. This allows healthcare companies to respond to the unmet needs of patients for effective and safe treatment and improved patient quality of life throughout the product lifecycle.

Matched MeSH terms: Republic of Korea
Prevalence, risk factors and secondary prevention of stroke recurrence in eight countries from south, east and southeast asia: a scoping review

Chin YY, Sakinah H, Aryati A, Hassan BM

Med J Malaysia, 2018 Apr;73(2):90-99.
PMID: 29703872

INTRODUCTION: In most Asian countries, stroke is one of the major causes of mortality. A stroke event is life-changing for stroke survivors, which results in either mortality or disability. Therefore, this study comprehensively focuses on prevalence, risk factors, and secondary prevention for stroke recurrence identified in South, East, and Southeast Asian countries.
METHODS: This scoping review uses the methodological framework of Arksey and O'Malley. A comprehensive search of academic journals (English) on this topic published from 2007 to 2017 was conducted. A total of 22 studies were selected from 585 studies screened from the electronic databases.
RESULTS: First-year stroke recurrence rates are in the range of 2.2% to 25.4%. Besides that, modifiable risk factors are significantly associated with pathophysiological factors (hypertension, ankle-brachial pressure index, atherogenic dyslipidaemia, diabetes mellitus, metabolic syndrome, and atrial fibrillation) and lifestyle factors (obesity, smoking, physical inactivity, and high salt intake). Furthermore, age, previous history of cerebrovascular events, and stroke subtype are also significant influence risk factors for recurrence. A strategic secondary prevention method for recurrent stroke is health education along with managing risk factors through a combination of appropriate lifestyle intervention and pharmacological therapy.
CONCLUSION: To prevent recurrent stroke, health intervention should be geared towards changing lifestyle to embody a healthier approach to life. This is of great importance to public health and stroke survivors' quality of life.

Matched MeSH terms: Republic of Korea/epidemiology

Filters

Please provide feedback to Administrator (afdal@afpm.org.my)

External Links